The Lawyer Global Litigation Top 50 report is the only ranking of international law firms by litigation and arbitration revenue and is essential reading for anyone seeking to benchmark their litigation and dispute resolution practices...
This year, The Lawyer’s annual ranking of the largest UK law firms by turnover is available as an interactive, digital benchmarking tool. For the first time this will allow you to manipulate each data set against the metrics of your choice.
Lovells has strengthened its life sciences group with the addition of former Merck Sharp & Dohme legal director Marc Dalby, a client of the firm.
At Merck Sharp & Dohme, the UK subsidiary of Merck & Co, Dalby was company secretary in addition to his role as legal director. He has not been replaced yet.
Dalby joined the City firm today as a consultant in the life sciences team. He has a particular focus on the regulation of pharmaceutical promotion, competition law, product liability and data exclusivity.
Dalby has been a longstanding member of the legal affairs committee of the Association of the British Pharmaceutical Industry (ABPI) and has sat on a number of ABPI working groups and sub-committees.
He was called to the bar in 1986 and went on to practice at 5 King's Bench Walk. He has also held legal positions at Lloyd's of London and Napp Pharmaceuticals.